Feasibility and Acceptability of Cognitive Behavioral Therapy for Chronic Insomnia in a Primary Care
Primary Purpose
Insomnia Chronic
Status
Completed
Phase
Not Applicable
Locations
Study Type
Interventional
Intervention
Cognitive behavioral therapy for insomnia
Sponsored by
About this trial
This is an interventional treatment trial for Insomnia Chronic focused on measuring primary care, cognitive behavioral therapy, clinical trial, feasibility-pilot study
Eligibility Criteria
Inclusion criteria:
- 18 to 65 years-old
- Diagnoses of chronic insomnia according to the Insomnia Severity Index (ISI equal or higher than 8) and had insomnia longer than 3 months;
- Did or did not use a hypnotic medication.
Exclusion criteria:
- Clinical diagnosis of secondary insomnia or another sleep disorder, such as restless legs syndrome, parasomnia, or alterations of the circadian rhythm (e.g., due to shift work)
- Use of a medication that could produce sleep alterations
- Severe psychiatric disorder; depression (HADS score ≥ 8) or diagnosis of major depression in the clinical records
- Suicide attempt
- Use of an antidepressant or anti-psychotic medication
- Alcohol or drug abuse during the last year
- Reception of another CBT-i
- Sleep apnea
- Dementia or presence of a cognitive deficit (Mini Mental State Evaluation score lower than 23)
- Neurodegenerative or oncological disease with poor prognosis
- Mental or physical incapacities that impeded participation in interviews
- Acute or chronic pain secondary to a rheumatic disease or another untreated chronic disease
- Pregnancy
- Participation in a previous clinical trial in the participating health centers
Sites / Locations
Arms of the Study
Arm 1
Arm 2
Arm Type
Experimental
No Intervention
Arm Label
Cognitive behavioral therapy (CBT)
Usual care
Arm Description
5 sessions of Cognitive behavioral therapy for insmonia and an extra session for benzodiazepine withdrawal (if necessary). The CBT-i included sleep hygiene counseling, stimulus control, cognitive restructuring, relaxation techniques, and benzodiazepine therapy or withdrawal
Usual care from GPs or nurses
Outcomes
Primary Outcome Measures
Acceptability of the training of PCPs
Satisfaction with training content and its ability to provide sufficient training measured though 2 nominal groups with a previous script
Secondary Outcome Measures
Feasibility of the intervention
Adequacy of sessions in terms of content, duration and number, fitting in PCPs agenda and patients acceptance.
Feasibility of the study design
Number of patients eligible identified and included, number of PCP randomized, number of patients followed up,completion of follow up and adherence to intervention sessions.
Intervention Effectiveness: Sleep
The Pittsburgh Sleep Quality Index (PSQI) is a 19-items self reported questionnaire that assesses 7 clinical components of sleep quality. Each item is rated on 0 to 3 point scale in which 0 is equal to not in the past month and 3 is equal to 3 or more times a week, with a global score range from 0 to 21. A cut off score of 5 has shown to discriminate between good and bad sleepers.
Intervention Effectiveness:Anxiety
The Hospital Anxiety and Depression Scale (HADS) measures anxiety and depression levels in the preceding week. It is 14-item self-report scale with two 7-item anxiety or depression subscales. Each item scores from 0 to 3 point scale giving maximum subscale scores of 21. Patients with scores >10 are considered to have morbidity, between 8 and 10 as borderline cases and <8 absence of relevant
Full Information
NCT ID
NCT04565223
First Posted
August 28, 2020
Last Updated
September 21, 2020
Sponsor
Balearic Islands Health Service (Ibsalut)
1. Study Identification
Unique Protocol Identification Number
NCT04565223
Brief Title
Feasibility and Acceptability of Cognitive Behavioral Therapy for Chronic Insomnia in a Primary Care
Official Title
Asessing the Feasibility and Acceptability of a Cluster Randomized Study of Cognitive Behavioral Therapy for Chronic Insomnia in a Primary Care.
Study Type
Interventional
2. Study Status
Record Verification Date
September 2020
Overall Recruitment Status
Completed
Study Start Date
September 1, 2014 (Actual)
Primary Completion Date
April 1, 2015 (Actual)
Study Completion Date
November 1, 2015 (Actual)
3. Sponsor/Collaborators
Responsible Party, by Official Title
Principal Investigator
Name of the Sponsor
Balearic Islands Health Service (Ibsalut)
4. Oversight
Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
No
Data Monitoring Committee
No
5. Study Description
Brief Summary
This pilot-feasibility study of a cluster parallel randomized design comparing CBT-i against usual care (UC) was performed at two primary health care centers in Majorca, Spain. Patients were included if they were 18 to 65 years-old; had diagnoses of chronic insomnia according to the Insomnia Severity Index (ISI more than 8) and had insomnia longer than 3 months; and did or did not use a hypnotic medication. 25 GPs and nurses and 32 patients were randomly allocated to two groups: The outcome of the trial was improving the quality of sleep. Other primary outcomes on feasibility and applicability of the intervention were collected through nominal groups. Description of usual care was described through previous studies. Moreover we assessed recruitment process, compliance with the intervention sessions, and patient's retention.
Detailed Description
Objectives
The primary objectives of this pilot-feasibility study were:
To design and adapt a brief CBT-i intervention to be provided by PCPs for the treatment of chronic insomnia in individuals who are 18 to 65 years-old.
To define usual care (UC) for the treatment of chronic insomnia provided by PCPs as a comparative intervention (control group).
To assess the training activities for the CBT-i intervention by determining GPs' and nurses' satisfaction with the content and applicability of the intervention.
To determine the acceptability of the intervention by GPs and nurses.
To assess PCPs and patient recruitment, follow-up, and adherence to the intervention The secondary objective was to assess the quality of sleep in patients after 3 months of the CBT-i.
Methods Design This pilot-feasibility study of a cluster parallel randomized design comparing CBT-I against usual care (UC) was performed from September 2014 to April 2015 at two primary health care centers of Majorca (Spain) with 56,000 registered inhabitants.
Collection of information and follow up Intervention The CBT-i intervention was developed by two family physicians (IT and CV) and two psychologists (ET and MRP-P). First, a review of the literature on the use of CBT-i was performed, with a focus on interventions applied in primary care. After the literature review, the CBT-i created by Morin [24] was adapted to our setting, in which there were fewer sessions and shorter sessions. The CBT-i included sleep hygiene counseling, stimulus control, cognitive restructuring, relaxation techniques, and benzodiazepine therapy or withdrawal (when needed). To conduct the intervention, guidelines for GPs and nurses and graphic and written materials for patients (sleep diary, registry of behavior habits, and cognitive problems) were developed.
Usual care The usual treatment for persistent insomnia in a primary care setting was previously described in two cross-sectional studies performed by general practitioners and family nurses of the Primary Care Majorca Department during 2011 and 2015
6. Conditions and Keywords
Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Insomnia Chronic
Keywords
primary care, cognitive behavioral therapy, clinical trial, feasibility-pilot study
7. Study Design
Primary Purpose
Treatment
Study Phase
Not Applicable
Interventional Study Model
Parallel Assignment
Masking
None (Open Label)
Allocation
Randomized
Enrollment
32 (Actual)
8. Arms, Groups, and Interventions
Arm Title
Cognitive behavioral therapy (CBT)
Arm Type
Experimental
Arm Description
5 sessions of Cognitive behavioral therapy for insmonia and an extra session for benzodiazepine withdrawal (if necessary).
The CBT-i included sleep hygiene counseling, stimulus control, cognitive restructuring, relaxation techniques, and benzodiazepine therapy or withdrawal
Arm Title
Usual care
Arm Type
No Intervention
Arm Description
Usual care from GPs or nurses
Intervention Type
Behavioral
Intervention Name(s)
Cognitive behavioral therapy for insomnia
Intervention Description
is a multicomponent intervention which focuses on cognitive and behavioral factors that contribute to sleep disorders , The CBT-i included sleep hygiene counseling, stimulus control, cognitive restructuring, relaxation techniques, and benzodiazepine therapy or withdrawal (when needed). To conduct the intervention, guidelines for GPs and nurses and graphic and written materials for patients (sleep diary, registry of behavior habits, and cognitive problems) were developed
Primary Outcome Measure Information:
Title
Acceptability of the training of PCPs
Description
Satisfaction with training content and its ability to provide sufficient training measured though 2 nominal groups with a previous script
Time Frame
3 months postintervention
Secondary Outcome Measure Information:
Title
Feasibility of the intervention
Description
Adequacy of sessions in terms of content, duration and number, fitting in PCPs agenda and patients acceptance.
Time Frame
3 months postintervention
Title
Feasibility of the study design
Description
Number of patients eligible identified and included, number of PCP randomized, number of patients followed up,completion of follow up and adherence to intervention sessions.
Time Frame
3 months postintervention
Title
Intervention Effectiveness: Sleep
Description
The Pittsburgh Sleep Quality Index (PSQI) is a 19-items self reported questionnaire that assesses 7 clinical components of sleep quality. Each item is rated on 0 to 3 point scale in which 0 is equal to not in the past month and 3 is equal to 3 or more times a week, with a global score range from 0 to 21. A cut off score of 5 has shown to discriminate between good and bad sleepers.
Time Frame
pretreatment and 3 months postintervention
Title
Intervention Effectiveness:Anxiety
Description
The Hospital Anxiety and Depression Scale (HADS) measures anxiety and depression levels in the preceding week. It is 14-item self-report scale with two 7-item anxiety or depression subscales. Each item scores from 0 to 3 point scale giving maximum subscale scores of 21. Patients with scores >10 are considered to have morbidity, between 8 and 10 as borderline cases and <8 absence of relevant
Time Frame
pretreatment and 3 months postintervention
10. Eligibility
Sex
All
Minimum Age & Unit of Time
18 Years
Maximum Age & Unit of Time
65 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion criteria:
18 to 65 years-old
Diagnoses of chronic insomnia according to the Insomnia Severity Index (ISI equal or higher than 8) and had insomnia longer than 3 months;
Did or did not use a hypnotic medication.
Exclusion criteria:
Clinical diagnosis of secondary insomnia or another sleep disorder, such as restless legs syndrome, parasomnia, or alterations of the circadian rhythm (e.g., due to shift work)
Use of a medication that could produce sleep alterations
Severe psychiatric disorder; depression (HADS score ≥ 8) or diagnosis of major depression in the clinical records
Suicide attempt
Use of an antidepressant or anti-psychotic medication
Alcohol or drug abuse during the last year
Reception of another CBT-i
Sleep apnea
Dementia or presence of a cognitive deficit (Mini Mental State Evaluation score lower than 23)
Neurodegenerative or oncological disease with poor prognosis
Mental or physical incapacities that impeded participation in interviews
Acute or chronic pain secondary to a rheumatic disease or another untreated chronic disease
Pregnancy
Participation in a previous clinical trial in the participating health centers
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Isabel Torrens, MD
Organizational Affiliation
Santa Ponça health Care Center
Official's Role
Principal Investigator
12. IPD Sharing Statement
Plan to Share IPD
No
IPD Sharing Plan Description
Data not shared
Citations:
PubMed Identifier
33863276
Citation
Torrens I, Esteva M, Vicens C, Piza-Portell MR, Vidal-Thomas MC, Vidal-Ribas C, Lorente-Montalvo P, Torres-Solera E. Assessing the feasibility and acceptability of a cluster-randomized study of cognitive behavioral therapy for chronic insomnia in a primary care setting. BMC Fam Pract. 2021 Apr 16;22(1):77. doi: 10.1186/s12875-021-01429-5.
Results Reference
derived
Learn more about this trial
Feasibility and Acceptability of Cognitive Behavioral Therapy for Chronic Insomnia in a Primary Care
We'll reach out to this number within 24 hrs